Aggregation and proteasome: The case of elongated polyglutamine aggregation in spinal and bulbar muscular atrophy

Neurobiology of Aging

Volumn 28, Issue 7, 2007, Pages 1099-1111

  Rusmini, Paola ^a,b   Sau, Daniela ^a,b   Crippa, Valeria ^a,b   Palazzolo, Isabella ^a,b   Simonini, Francesca ^a,b   Onesto, Elisa ^a,b   Martini, Luciano ^a,b   Poletti, Angelo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Aggregation; Androgen receptor; Antiandrogen; Inclusion; Motor neuron diseases; Neurodegeneration; Polyglutamine diseases; Proteasome; Spinal and bulbar muscular atrophy; Testosterone

Indexed keywords

ANDROGEN RECEPTOR; ANTIANDROGEN; POLYGLUTAMINE; PROTEASOME; TESTOSTERONE; YELLOW FLUORESCENT PROTEIN;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; KENNEDY DISEASE; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

ANIMALS; CELL LINE, TRANSFORMED; HUMANS; LUMINESCENT PROTEINS; MICE; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; MUTATION; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TESTOSTERONE; TRANSFECTION; TRINUCLEOTIDE REPEAT EXPANSION; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 34247365603     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2006.05.015     Document Type: Article

References (55)

1. Adachi H., Katsuno M., Minamiyama M., Waza M., Sang C., Nakagomi Y., et al. Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients. Brain Res 128 (2005) 659-670
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
3. Becker M., Martin E., Schneikert J., Krug H.F., and Cato A.C. Cytoplasmic localization and the choice of ligand determine aggregate formation by androgen receptor with amplified polyglutamine stretch. J Cell Biol 149 (2000) 255-262
4. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
5. Bennett E.J., Bence N.F., Jayakumar R., and Kopito R.R. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17 (2005) 351-365
6. Cardozo C.P., Michaud C., Ost M.C., Fliss A.E., Yang E., Patterson C., et al. C-terminal hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. Arch Biochem Biophys 410 (2003) 134-140
7. Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., et al. Neuroblastoma × spinal cord (nsc) hybrid cell lines resemble developing motor neurons. Devel Dyn 194 (1992) 209-221
8. Chai Y., Shao J., Miller V.M., Williams A., and Paulson H.L. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis. Proc Natl Acad Sci USA 99 (2002) 9310-9315
9. Chevalier-Larsen E.S., O'Brien C.J., Wang H., Jenkins S.C., Holder L., Lieberman A.P., et al. Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy. J Neurosci 24 (2004) 4778-4786
10. Ciechanover A., and Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron 40 (2003) 427-446
11. Fischbeck K.H. Polyglutamine expansion neurodegenerative disease. Brain Res Bull 56 (2001) 161-163
12. Furutani T., Takeyama K.I., Tanabe M., Koutoku H., Ito S., Taniguchi N., et al. Human expanded polyq androgen receptor mutants in neurodegeneration as a novel ligand target. J Pharmacol Exp Ther (2005)
13. Gelmann E.P. Molecular biology of the androgen receptor. J Clin Oncol 20 (2002) 3001-3015
14. Georget V., Terouanne B., Nicolas J.C., and Sultan C. Mechanism of antiandrogen action: Key role of hsp90 in conformational change and transcriptional activity of the androgen receptor. Biochemistry 41 (2002) 11824-11831
15. Gioeli D., Ficarro S.B., Kwiek J.J., Aaronson D., Hancock M., Catling A.D., et al. Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem 277 (2002) 29304-29314
16. Holmberg C.I., Staniszewski K.E., Mensah K.N., Matouschek A., and Morimoto R.I. Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 23 (2004) 4307-4318
17. Huynh D.P., Yang H.T., Vakharia H., Nguyen D., and Pulst S.M. Expansion of the polyq repeat in ataxin-2 alters its golgi localization, disrupts the golgi complex and causes cell death. Hum Mol Genet 12 (2003) 1485-1496
18. Iwata A., Christianson J.C., Bucci M., Ellerby L.M., Nukina N., Forno L.S., et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc Natl Acad Sci USA (2005)
19. Katsuno M., Adachi H., Doyu M., Minamiyama M., Sang C., Kobayashi Y., et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat Med 9 (2003) 768-773
20. Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35 (2002) 843-854
21. Kim S., Nollen E.A., Kitagawa K., Bindokas V.P., and Morimoto R.I. Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4 (2002) 826-831
22. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., et al. Ataxin-1 nuclear localization and aggregation-role in polyglutamine-induced disease in sca1 transgenic mice. Cell 95 (1998) 41-53
23. Kuil C.W., Berrevoets C.A., and Mulder E. Ligand-induced conformational alterations of the androgen receptor analyzed by limited trypsinization. Studies on the mechanism of antiandrogen action. J Biol Chem 270 (1995) 27569-27576
24. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in x-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
25. Marcelli M., Stenoien D.L., Szafran A.T., Simeoni S., Agoulnik I.U., Weigel N.L., et al. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem 98 (2006) 770-788
26. Marron T.U., Guerini V., Rusmini P., Sau D., Brevini T.A.L., Martini L., et al. Androgen-induced neurite outgrowth is mediated by neuritin in motor neurones. J Neurochem 92 (2005) 10-20
27. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., et al. Creb-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 9 (2000) 2197-2202
28. Muchowski P.J., Ning K., D'Souza-Schorey C., and Fields S. Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment. Proc Natl Acad Sci USA 99 (2002) 727-732
29. Newmeyer D.D., and Forbes D.J. Nuclear import can be separated into distinct steps in vitro: nuclear pore binding and translocation. Cell 52 (1988) 641-653
30. Ohara-Nemoto Y., Nemoto T., Sato N., and Ota M. Characterization of the nontransformed and transformed androgen receptor and heat shock protein 90 with high-performance hydrophobic-interaction chromatography. J Steroid Biochem 31 (1988) 295-304
31. Ozanne D.M., Brady M.E., Cook S., Gaughan L., Neal D.E., and Robson C.N. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol 14 (2000) 1618-1626
32. Pawlowski J.E., Ertel J.R., Allen M.P., Xu M., Butler C., Wilson E.M., et al. Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. J Biol Chem 277 (2002) 20702-20710
33. Piccioni F., Simeoni S., Andriola I., Armatura E., Bassanini S., Pozzi P., et al. Polyglutamine tract expansion of the androgen receptor in a motoneuronal model of spinal and bulbar muscular atrophy. Brain Res Bull 56 (2001) 215-220
34. Piccioni F., Pinton P., Simeoni S., Pozzi P., Fascio U., Vismara G., et al. Androgen receptor with elongated polyglutamine tract forms aggregates that alter axonal trafficking and mitochondrial distribution in motor neuronal processes. FASEB J 160 (2002) 1418-1420
35. Poletti A. The polyglutamine tract of androgen receptor: From functions to dysfunctions in motor neurons. Front Neuroendocrinol 25 (2004) 1-26
36. Pozzi P., Bendotti C., Simeoni S., Piccioni F., Guerini V., Marron T.U., et al. Androgen 5-alpha-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J Neuroendocrinol 15 (2003) 882-887
37. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl (2004) S10-S17
38. Saudou F., Finkbeiner S., Devys D., and Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95 (1998) 55-66
39. Schmidt B.J., Greenberg C.R., Allingham-Hawkins D.J., and Spriggs El. Expression of x-linked bulbospinal muscular atrophy (kennedy disease) in two homozygous women. Neurology 59 (2002) 770-772
40. Simeoni S., Mancini M.A., Stenoien D.L., Marcelli M., Weigel N.L., Zanisi M., et al. Motoneuronal cell death is not correlated with aggregate formation of androgen receptors containing an elongated polyglutamine tract. Hum Mol Genet 9 (2000) 133-144
41. Sittler A., Walter S., Wedemeyer N., Hasenbank R., Scherzinge E., Eickhof fH., et al. Sh3gl3 associates with the huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol Cell 2 (1998) 427-436
42. Stenoien D.L., Mielke M., and Mancini M.A. Intranuclear ataxin1 inclusions contain both fast- and slow-exchanging components. Nat Cell Biol 10 (2002) 806-810
43. Stenoien D.L., Cummings C.J., Adams H.P., Mancini M.G., Patel K., DeMartino G., et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and src-1, and are suppressed by the hdj-2 chaperone. Hum Mol Genet 8 (1999) 731-741
44. Tagawa K., Hoshino M., Okuda T., Ueda H., Hayashi H., Engemann S., et al. Distinct aggregation and cell death patterns among different types of primary neurons induced by mutant huntingtin protein. J Neurochem 89 (2004) 974-987
45. Taylor J.P., Tanaka F., Robitschek J., Sandoval C.M., Taye A., Markovic-Plese S., et al. Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein. Hum Mol Genet 12 (2003) 749-757
46. Thomas M., Dadgar N., Aphale A., Harrell J.M., Kunkel R., Pratt W.B., et al. Androgen receptor acetylation site mutations cause trafficking defects, misfolding, and aggregation similar to expanded glutamine tracts. J Biol Chem 279 (2004) 8389-8395
47. Trapman J., Klaassen P., Kuiper G.G.J.M., van der Korput J.A.G.M., Faber P.W., van Rooij H.C.J., et al. Cloning, structure and expression of a CDNA encoding the human androgen receptor. Biochem Biophys Res Commun 153 (1988) 241-248
48. Veldscholte J., Berrevoets C.A., Brinkmann A.O., Grootegoed J.A., and Mulder E. Anti-androgens and the mutated androgen receptor of lncap cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation. Biochemistry 31 (1992) 2393-2399
49. Verrijdt G., Haelens A., and Claessens F. Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78 (2003) 175-185
50. Walcott J.L., and Merry D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J Biol Chem 277 (2002) 50855-50859
51. Webb J.L., Ravikumar B., and Rubinsztein D.C. Microtubule disruption inhibits autophagosome-lysosome fusion: implications for studying the roles of aggresomes in polyglutamine diseases. Int J Biochem Cell Biol 36 (2004) 2541-2550
52. Wen W., Meinkoth J.L., Tsien R.Y., and Taylor S.S. Identification of a signal for rapid export of proteins from the nucleus. Cell 82 (1995) 463-473
53. Whitaker H.C., Hanrahan S., Totty N., Gamble S.C., Waxman J., Cato A.C., et al. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens. Clin Cancer Res 10 (2004) 7392-7401
54. Woodham C., Birch L., and Prins G.S. Neonatal estrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinology 144 (2003) 4841-4850
55. Zhou Z.X., Lane M.V., Kemppainen J.A., French F.S., and Wilson E.M. Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor. Mol Endocrinol 9 (1995) 208-218